Consistent with our functional results, h219-LLG increased percentages of CD4 memory T cells and inflammatory macrophages, but decreased those of pro-tumor macrophages, Tregs, and plasmacytoid dendritic cells (Figures 6F, G). The gene discussed is CD4; the disease is neoplasm.